WO1998034108A1 - Diagnostic compositions and devices utilizing same - Google Patents

Diagnostic compositions and devices utilizing same Download PDF

Info

Publication number
WO1998034108A1
WO1998034108A1 PCT/US1997/011177 US9711177W WO9834108A1 WO 1998034108 A1 WO1998034108 A1 WO 1998034108A1 US 9711177 W US9711177 W US 9711177W WO 9834108 A1 WO9834108 A1 WO 9834108A1
Authority
WO
WIPO (PCT)
Prior art keywords
dye
composition
mbth
fluid sample
systems
Prior art date
Application number
PCT/US1997/011177
Other languages
French (fr)
Inventor
Joel S. Douglas
Karen R. Drexler
Original Assignee
Mercury Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/628,794 priority Critical patent/US5776719A/en
Application filed by Mercury Diagnostics, Inc. filed Critical Mercury Diagnostics, Inc.
Priority to AU40387/97A priority patent/AU4038797A/en
Priority to DE19781511T priority patent/DE19781511B4/en
Priority to JP2000572541A priority patent/JP2002525619A/en
Priority to PCT/US1997/011177 priority patent/WO1998034108A1/en
Priority to GB9811951A priority patent/GB2329246B/en
Priority to US09/037,653 priority patent/US5885790A/en
Publication of WO1998034108A1 publication Critical patent/WO1998034108A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
    • C12Q2326/32—3-Methyl-2-benzothiazolinone hydrazone hydrochloride hydrate, i.e. MBTH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/808—Optical sensing apparatus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide

Definitions

  • the present invention relates to dye compositions used for colorimetric determination of a chemical or biochemical component (analyte) in an aqueous body fluid, such as blood.
  • analyte a chemical or biochemical component
  • the present invention relates to the field of dry reagent compositions for use on test strips adapted to receive a liquid sample of body fluid whereby the dye indicator composition wetted by the fluid reacts with the analyte and provides a visual or color indication of the presence or concentration of the analyte.
  • Indicator compositions for use in devices for color indication of various analytes in various body fluids are well known in the art and are embodied in numerous commercial products.
  • a dye composition or a dye couple composition is formulated in a solution which is applied to a test strip matrix then dried to form a dry chemistry system on the test strip.
  • the dry chemistry system commonly involve an oxidizable dye or dye couple in combination with a oxidase or peroxidase specific to the analyte to be tested.
  • the analyte reacts with the corresponding oxidase or peroxidase producing hydrogen peroxide which in turn oxidizes the dye or dye couple to produce the desired color change for indication of the presence or concentration of the analyte.
  • this invention provides a dye composition
  • a dye composition comprising 3- methyl-6(M sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S) where M is a positive ion providing a stable sulfonate salt and an oxidase enzyme or a peroxidase enzyme.
  • M is a positive ion providing a stable sulfonate salt and an oxidase enzyme or a peroxidase enzyme.
  • This dye composition is formulated into a dry chemistry indicator system including other dye compounds to form dye couple system and conventional binders, chelating agents, buffers and the like, as known in the art.
  • the MBTH-S is used in the composition in form of a stable sulfonate salt, of which the sodium salt is preferred, but the potassium, ammonium or other ionic form of the sulfonate salt may be used.
  • the MBTH-S is used with another dye compound to form a dye couple for improved indication and a desired pH range in the range of about 6.
  • this invention provides a device for testing a fluid for the presence or concentration of an analyte comprising a support for the dye composition wherein the dye composition comprises MBTH-S and an oxidase enzyme or a peroxidase enzyme as summarized above.
  • the various mechanical configurations of such devices are known in the art and various configurations may be used incorporating the MBTH-S dye system of this invention adapted as desired for particular testing to be accomplished.
  • this invention provides a method of testing a fluid for the presence or concentration of an analyte comprising contacting a fluid sample with a dry chemistry system comprising MBTH-S and an oxidase enzyme or a peroxidase enzyme as summarized above.
  • Figure 1 shows a comparison of the reflectance at certain light wavelengths of dye systems based on (MBTH-S)-ANS and based on MBTH- DMAB.
  • FIG. 2 is an illustration of the relative general activity of enzymes over a pH range. Detailed Description of the Invention
  • Dry chemistry indicator systems for use in test strips such as for testing for glucose in blood are well known in the art as illustrated by the prior art patents referred to above in the background section of this specification. Therefore this disclosure is directed to one skilled in the art having knowledge of how to formulate a dye or dye couple composition into a dry chemistry reagent system on a test strip.
  • the test strip typically is in the form of an absorbent matrix for containing the dry chemistry reagent indication system and for receiving the fluid sample to react with the dry chemistry reagent indicator system.
  • This invention provides an improved dye indicator system based on the use of 3-Methyl-6-(M sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S), wherein M is a positive ion providing a stable sulfonate salt, preferably sodium, potassium, ammonium or other equivalent ion.
  • Dry chemistry reagent dye systems formulated based on MBTH-S provide a dry chemistry system on test strips which are resistant to sublimation of the dye in the dry chemistry system and thus provide extended shelf life and increased reliability of the test strips containing the MBTH-S dye system.
  • dry chemistry reagent dye systems formulated based on the MBTH-S of this invention can be formulated and buffered to operate in a pH range of about 6, which provides additional stability of the oxidase enzymes or peroxidase enzymes present in the dye indicator system.
  • the dry chemistry reagent dye systems formulated based on the MBTH-S of this invention also provide a stable color reaction end point which is reached in a short period of time after applying the fluid sample. This enables the user to read and interpret the color indication without dependence on accurate timing or taking readings at specific time intervals, which usually requires the use of an electronic meter for accurate measurement and timing.
  • This end point stability of the dye system of this invention also enables the use of the test strip as at least a semi-permanent record of the test results.
  • the dye systems of this invention are useful in prior art devices and systems including those involving the reaction of whole blood or other unfiltered fluid with the dry chemistry reagent dye system. In such devices and systems the color presence of whole blood obscures to visual inspection the indicator color change, but these systems can be read and measured by reflectance at certain specific light wavelengths by an appropriate electronic meter system.
  • the dye systems according to this invention are particularly useful in devices and systems that separate the blood solids such as red blood cells from blood fluids and allow the clear blood fluids to contact and react with the dry chemistry reagent dye system, thus providing an unobscured, visually readable color change.
  • the dye system of the present invention is useful in the devices and systems disclosed in copending application Serial No. 08/628,489 filed on the same date at this application, which disclosure is incorporated herein by reference.
  • the MBTH-S dye system of this invention can be formulated and implemented in many of the dye systems previously based on MBTH by making the appropriate adjustment in buffer and other components to accommodate the different pH range and other properties of MBTH-S compared to the conventional MBTH.
  • the dry chemistry reagent dye system of this invention is formulated to enable to analyte to react with a specific oxidase enzyme to produce hydrogen peroxide which reacts with the MBTH-S indicator system according to this invention to produce a color change which is visually read or electronically measured with a meter.
  • the oxidase enzyme may be selected from glucose oxidase, cholesterol oxidase, uricase, alcohol oxidase, aldehyde oxidase, glycerophosphate oxidase or other similar oxidase enzymes known in the art to be particularly reactive with a particular analyte.
  • the system may also include the presence of a peroxidase enzyme such as horseradish peroxidase or other known peroxidase to produce or enhance the desired color change in the indicator.
  • a peroxidase enzyme such as horseradish peroxidase or other known peroxidase to produce or enhance the desired color change in the indicator.
  • the indicator reagent dye system is formulated in a solution and is typically impregnated into a porous matrix or membrane such as a polyethersulfone membrane available from Gelman Science, Ann Arbor, Michigan, or a fiberglass matrix available from AhlstromFiltration, Inc.,
  • the MBTH-S provided by this invention may be formulated in the dry chemistry reagent dye system alone or in combination with other dye components to form dye couple systems which preferably include 3,3-dimethylaminobenzoic acid (DMAB), 3,5-dichloro-2-hydroxybenzene- sulfonic acid (DCHBS),8-anilino-l-naphthalenesulfonate (ANS), or N-(3- sulfopropyl)aniline.
  • DMAB 3,3-dimethylaminobenzoic acid
  • DCHBS 3,5-dichloro-2-hydroxybenzene- sulfonic acid
  • ANS 8-anilino-l-naphthalenesulfonate
  • N-(3- sulfopropyl)aniline N-(3- sulfopropyl)aniline.
  • Other dye compounds which provide a sufficiently high extinction point (approx.
  • the MBTH-S and N-(3-sulfopropyl)aniline formulation is another preferred embodiment for the indicating dye system in the devices and methods of this invention. It creates a stable end point chemistry which is water soluble and does not sublime over time when applied and dried in the membrane matrix.
  • the MBTH-S coupled with ANS provides flat spectral absorption in the region of about 580 to 650 nm.
  • MBTH-S coupled with ANS provides good spectral absorption, is water soluble and does not sublime under dry chemistry storage conditions.
  • the selection of the additional dye components to be combined with the MBTH-S or to provide dye couple systems with MBTH-S will depend on the analyte to be detected, the conditions under which the test strip is to be stored and used and other conventional considerations.
  • the dye couple formed from the combination of MBTH-S and ANS provides a preferred dye couple system, particularly for formulation with glucose oxidase for glucose detection and measurement in blood fluids.
  • MBTH-S 3-Methyl-6-(M sulfonate)-benzothiazolinone-(2)- hydrazone
  • M is Na
  • the sodium sulfonate salt is preferred and is prepared as follows. 85 grams of 3-Methyl-benzothiazolinone-(2)-hydrazone (MBTH) is dissolved in 750 grams of 25% oleum situated in an ice bath so that the temperature is not allowed to exceed 30°C. Upon standing at room temperature for 12 hours complete solution is obtained.
  • the solution is poured into 8 liters of 0°C water containing excess ice to maintain the 0°C temperature. Upon standing for about 8 hours the free sulfonic acid precipitate is filtered out, washed and dried. Approximately 85 grams of crude product is obtained, which is purified by repeat extractions with boiling methanol. The resulting solid is washed with water and dissolved in an equimolar amount of 3N NaOH with heating. This solution is filtered over activated charcoal and treated with a double volume of dioxane then allowed to crystallize overnight at about 5°C. The product is then subjected to repeated recrystallizations from 10% NaAcetate with concurrent activated charcoal filtration until the material is almost white.
  • a dry chemistry reagent indicator dye system is formulated as follows: Test Reagents
  • Gantrez S95 available from GAF 250 mg Crotein SPA 20,500 units glucose oxidase
  • Figure 1 shows the comparative spectral reflective in the range of 520- 720 nm for the dye system of the present invention based on a MBTH-S-ANS dye couple compared to a MBTH-DMAB dye couple, such as disclosed in Kiser U.S. Patent No. 5,306,623.
  • Figure 2 is a general illustration of the peroxidase activity of enzymes over a pH range as can be seen it is preferred to have systems which can operate closer to a pH between about 6 and 7.
  • the dye system according to the present invention is stable at a buffered pH of about 6 thus enabling the dye system of this invention to operate in a pH range more favorable to the stability and activity of the oxidase enzymes and peroxidase enzymes present in the dye indicator system.
  • the MBTH-S dye indicator of this invention can be formulated in various systems with various oxidase and peroxidase material to provide desired indication of various analytes. It will also be apparent that the systems can be formulated at buffered Ph levels which provide a favorable environment for stability of the enzyme components in the dry chemistry reagent system and in the fluid to be analyzed.

Abstract

A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S). Preferred dye systems are based on the dye couple (MBTH-S) and 8-anilino-1-naphthalenesulfonate (ANS), and the dye couple MBTH-S and N-(3-sulfopropyl)analine. These dye indicator systems are used in conventional blood chemistry test strips and are particularly preferred for indication of glucose in blood.

Description

DIAGNOSTIC COMPOSITIONS AND DEVICES UTILIZING SAME
Field of the Invention The present invention relates to dye compositions used for colorimetric determination of a chemical or biochemical component (analyte) in an aqueous body fluid, such as blood. In particular the present invention relates to the field of dry reagent compositions for use on test strips adapted to receive a liquid sample of body fluid whereby the dye indicator composition wetted by the fluid reacts with the analyte and provides a visual or color indication of the presence or concentration of the analyte.
Background of the Invention Indicator compositions for use in devices for color indication of various analytes in various body fluids are well known in the art and are embodied in numerous commercial products. Typically a dye composition or a dye couple composition is formulated in a solution which is applied to a test strip matrix then dried to form a dry chemistry system on the test strip. The dry chemistry system commonly involve an oxidizable dye or dye couple in combination with a oxidase or peroxidase specific to the analyte to be tested. The analyte reacts with the corresponding oxidase or peroxidase producing hydrogen peroxide which in turn oxidizes the dye or dye couple to produce the desired color change for indication of the presence or concentration of the analyte.
Example of such dye and dye couple systems are disclosed by Phillips et al. in U.S. Patent Nos. 4,734,360; 5,059,394 and 5,304,468; by Yu in U.S. Patent No. 5,453,360; Hoenes in U.S. Patent No. 5,334,508 and by Hochstrasser in U.S. Patent Nos. 3,964,871 and 4,059,407.
The disclosures of the above patents are incorporated herein by reference.
A number of the indicator systems disclosed in the above references are incorporated into various commercial products. While the products generally provide acceptable indication and testing under some conditions, certain problems exist with the prior dye systems. For example, in some dye systems the dry chemistry dye system existing on the test strip will allow the dye compounds to sublime from the test strip so that when the test strip is used by the consumer it may not provide an accurate indication. This limits the shelf life of the test strips. In some dye systems the color change provided by the dye system continues to change over time rather than reaching a stable end point. In those dye systems, the color indication must be accurately read at specific time intervals in order to obtain accurate indication of analyte presence or concentration. Some dye systems require a low pH to provide the necessary stability of the dye system. If the pH is below the desired pH level for stability of the enzymes used in the dye system the amount of enzymes used in the formulation must be increased. In such a case this can cause the enzymes to produce undesired indications due to the instability of the enzymes at the low pH required for the dye system. In view of the above it is an object of this invention to provide an indicator dye system with improved stability to prevent sublimation of the dye system from the dry chemistry test strips.
It is an object of this invention to provide a dye system which will rapidly produce a stable end point thereby producing a final color indication in a short period of time thus eliminating the time dependent measurement or determination by the user.
It is a further object of this invention to provide a dye system which can be formulated and used a more normal pH to provide a more stable system for the enzymes present during the manufacture or use of the dye system. The above objects as well as others are achieved by the compositions and systems of this invention as disclosed herein.
Summary of the Invention In one aspect this invention provides a dye composition comprising 3- methyl-6(M sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S) where M is a positive ion providing a stable sulfonate salt and an oxidase enzyme or a peroxidase enzyme. This dye composition is formulated into a dry chemistry indicator system including other dye compounds to form dye couple system and conventional binders, chelating agents, buffers and the like, as known in the art. The MBTH-S is used in the composition in form of a stable sulfonate salt, of which the sodium salt is preferred, but the potassium, ammonium or other ionic form of the sulfonate salt may be used. In a preferred aspect of this invention the MBTH-S is used with another dye compound to form a dye couple for improved indication and a desired pH range in the range of about 6.
In another aspect this invention provides a device for testing a fluid for the presence or concentration of an analyte comprising a support for the dye composition wherein the dye composition comprises MBTH-S and an oxidase enzyme or a peroxidase enzyme as summarized above. The various mechanical configurations of such devices are known in the art and various configurations may be used incorporating the MBTH-S dye system of this invention adapted as desired for particular testing to be accomplished. In another aspect this invention provides a method of testing a fluid for the presence or concentration of an analyte comprising contacting a fluid sample with a dry chemistry system comprising MBTH-S and an oxidase enzyme or a peroxidase enzyme as summarized above.
Brief Description of the Drawings Figure 1 shows a comparison of the reflectance at certain light wavelengths of dye systems based on (MBTH-S)-ANS and based on MBTH- DMAB.
Figure 2 is an illustration of the relative general activity of enzymes over a pH range. Detailed Description of the Invention
Dry chemistry indicator systems for use in test strips such as for testing for glucose in blood, are well known in the art as illustrated by the prior art patents referred to above in the background section of this specification. Therefore this disclosure is directed to one skilled in the art having knowledge of how to formulate a dye or dye couple composition into a dry chemistry reagent system on a test strip. The test strip typically is in the form of an absorbent matrix for containing the dry chemistry reagent indication system and for receiving the fluid sample to react with the dry chemistry reagent indicator system.
This invention provides an improved dye indicator system based on the use of 3-Methyl-6-(M sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S), wherein M is a positive ion providing a stable sulfonate salt, preferably sodium, potassium, ammonium or other equivalent ion. Dry chemistry reagent dye systems formulated based on MBTH-S provide a dry chemistry system on test strips which are resistant to sublimation of the dye in the dry chemistry system and thus provide extended shelf life and increased reliability of the test strips containing the MBTH-S dye system. In addition, dry chemistry reagent dye systems formulated based on the MBTH-S of this invention can be formulated and buffered to operate in a pH range of about 6, which provides additional stability of the oxidase enzymes or peroxidase enzymes present in the dye indicator system. In addition, the dry chemistry reagent dye systems formulated based on the MBTH-S of this invention also provide a stable color reaction end point which is reached in a short period of time after applying the fluid sample. This enables the user to read and interpret the color indication without dependence on accurate timing or taking readings at specific time intervals, which usually requires the use of an electronic meter for accurate measurement and timing. This end point stability of the dye system of this invention also enables the use of the test strip as at least a semi-permanent record of the test results.
The dye systems of this invention are useful in prior art devices and systems including those involving the reaction of whole blood or other unfiltered fluid with the dry chemistry reagent dye system. In such devices and systems the color presence of whole blood obscures to visual inspection the indicator color change, but these systems can be read and measured by reflectance at certain specific light wavelengths by an appropriate electronic meter system. The dye systems according to this invention are particularly useful in devices and systems that separate the blood solids such as red blood cells from blood fluids and allow the clear blood fluids to contact and react with the dry chemistry reagent dye system, thus providing an unobscured, visually readable color change. In particular the dye system of the present invention is useful in the devices and systems disclosed in copending application Serial No. 08/628,489 filed on the same date at this application, which disclosure is incorporated herein by reference.
In general it will be recognized by those skilled in the art that the MBTH-S dye system of this invention can be formulated and implemented in many of the dye systems previously based on MBTH by making the appropriate adjustment in buffer and other components to accommodate the different pH range and other properties of MBTH-S compared to the conventional MBTH.
The dry chemistry reagent dye system of this invention is formulated to enable to analyte to react with a specific oxidase enzyme to produce hydrogen peroxide which reacts with the MBTH-S indicator system according to this invention to produce a color change which is visually read or electronically measured with a meter. The oxidase enzyme may be selected from glucose oxidase, cholesterol oxidase, uricase, alcohol oxidase, aldehyde oxidase, glycerophosphate oxidase or other similar oxidase enzymes known in the art to be particularly reactive with a particular analyte. The system may also include the presence of a peroxidase enzyme such as horseradish peroxidase or other known peroxidase to produce or enhance the desired color change in the indicator. The indicator reagent dye system is formulated in a solution and is typically impregnated into a porous matrix or membrane such as a polyethersulfone membrane available from Gelman Science, Ann Arbor, Michigan, or a fiberglass matrix available from AhlstromFiltration, Inc.,
Chattanooga, Tenn., and dried to provide a dry chemistry system useful in the conventional test strips. The MBTH-S provided by this invention may be formulated in the dry chemistry reagent dye system alone or in combination with other dye components to form dye couple systems which preferably include 3,3-dimethylaminobenzoic acid (DMAB), 3,5-dichloro-2-hydroxybenzene- sulfonic acid (DCHBS),8-anilino-l-naphthalenesulfonate (ANS), or N-(3- sulfopropyl)aniline. Other dye compounds which provide a sufficiently high extinction point (approx. 7.0 or higher is preferred) and which form an appropriate dye couple with MBTH-S can be used in the dye system of this invention. Formulation thereof will be apparent to one skilled in the art following the teachings herein. Reference is made to the Reagents Catalog from Dojindo Laboratories, Tokyo, Japan, and to a paper entitled "Reagents Used for Detecting Substances in Biological Matrix by Enzymatic Methods" published by Dojindo Laboratories at a 1995 Pacific Rim Conference, for dyes of appropriate properties for use in this invention. By using MBTH-S and ANS a dye couple can be used which exists at a pH of 6 which permits the dye couple dry chemistry system to be used at this higher pH. It has been found that the MBTH-S and N-(3-sulfopropyl)aniline formulation is another preferred embodiment for the indicating dye system in the devices and methods of this invention. It creates a stable end point chemistry which is water soluble and does not sublime over time when applied and dried in the membrane matrix. The MBTH-S coupled with ANS provides flat spectral absorption in the region of about 580 to 650 nm. MBTH-S coupled with ANS provides good spectral absorption, is water soluble and does not sublime under dry chemistry storage conditions. It will be apparent to one skilled in the art that the selection of the additional dye components to be combined with the MBTH-S or to provide dye couple systems with MBTH-S will depend on the analyte to be detected, the conditions under which the test strip is to be stored and used and other conventional considerations. However it has been found that the dye couple formed from the combination of MBTH-S and ANS provides a preferred dye couple system, particularly for formulation with glucose oxidase for glucose detection and measurement in blood fluids.
The preparation of 3-Methyl-6-(M sulfonate)-benzothiazolinone-(2)- hydrazone (MBTH-S) will be apparent to one skilled in the art as being the sulfonation of MBTH. The preferred MBTH-S is where M is Na. In this instance the sodium sulfonate salt is preferred and is prepared as follows. 85 grams of 3-Methyl-benzothiazolinone-(2)-hydrazone (MBTH) is dissolved in 750 grams of 25% oleum situated in an ice bath so that the temperature is not allowed to exceed 30°C. Upon standing at room temperature for 12 hours complete solution is obtained. The solution is poured into 8 liters of 0°C water containing excess ice to maintain the 0°C temperature. Upon standing for about 8 hours the free sulfonic acid precipitate is filtered out, washed and dried. Approximately 85 grams of crude product is obtained, which is purified by repeat extractions with boiling methanol. The resulting solid is washed with water and dissolved in an equimolar amount of 3N NaOH with heating. This solution is filtered over activated charcoal and treated with a double volume of dioxane then allowed to crystallize overnight at about 5°C. The product is then subjected to repeated recrystallizations from 10% NaAcetate with concurrent activated charcoal filtration until the material is almost white. The final material is recrystallized from water and washed with 70% dioxane, then with pure dioxane, then with ether. The resulting crystals of 3-Methyl-6-(sodium sulfonate)-benzothiazolinone-(2)-hydrazone are air dried.
A dry chemistry reagent indicator dye system is formulated as follows: Test Reagents
Reagent lb 20 ml water 420 mg citric acid (a buffering agent). Adjust th pH of the citric acid solution with NaOH to a value of 4.25. 16.7 mg EDTA
90 mg Gantrez S95 available from GAF 250 mg Crotein SPA 20,500 units glucose oxidase
16,200 units peroxidase Reagent 2b 10 ml of a mixture of 3 parts by volume water and 7 parts by volume isopropyl alcohol 13 mg MBTH-S 40 mg ANS A piece of polyethersulfone membrane from Gelman Science is uniformly coated with reagent lb; the excess is wiped off and the membrane dried. The membrane is then coated with reagent 2b in the same fashion and dried. The membrane is then assembled into a test device as shown in Figure 2 of copending application Serial No. 08/628,489 referred above. Whole blood is applied to the test area and the glucose level is read by visual inspection of the color indication on of the test side of the device. The color changes from clear to a purple to blue color and the final color end point forms from clear which is achieved in about 45 seconds and the end point color is calibrated to known concentrations of glucose.
Figure 1 shows the comparative spectral reflective in the range of 520- 720 nm for the dye system of the present invention based on a MBTH-S-ANS dye couple compared to a MBTH-DMAB dye couple, such as disclosed in Kiser U.S. Patent No. 5,306,623. Figure 2 is a general illustration of the peroxidase activity of enzymes over a pH range as can be seen it is preferred to have systems which can operate closer to a pH between about 6 and 7. The dye system according to the present invention is stable at a buffered pH of about 6 thus enabling the dye system of this invention to operate in a pH range more favorable to the stability and activity of the oxidase enzymes and peroxidase enzymes present in the dye indicator system.
It will be apparent to one skilled in the art the MBTH-S dye indicator of this invention can be formulated in various systems with various oxidase and peroxidase material to provide desired indication of various analytes. It will also be apparent that the systems can be formulated at buffered Ph levels which provide a favorable environment for stability of the enzyme components in the dry chemistry reagent system and in the fluid to be analyzed.

Claims

We claim:
1. A device for testing the presence or concentration of an analyte in a fluid sample comprising: a support member, a composition positioned on or impregnated in said support said composition comprising a composition for a dry chemistry reagent indicator comprising 3-Methyl-6-(M sulfonate)-benzothiazolinone-(2)-hydrazone, wherein M is a positive charge ion providing a stable aqueous salt thereof, a second dye component selected from the group consisting of 3,3-dimethylaminobenzoic acid, 3,5-dichloro-2-hydroxybenzenesulfonic acid, 8-anilino-l- naphthalenesulfonate and N-(3-sulfopropyl)aniline and an oxidase enzyme or a peroxidase enzyme; whereby the support member is adapted for receiving a fluid sample such that the fluid sample contacts said composition and adapted such that the support provides for inspection or reading of the color change produced by said composition after contact with the fluid sample.
2. A device according to claim 1 wherein M is a sodium, potassium or ammonium ion.
3. A device according to claim 1 wherein the second dye component is 8-anilino-l-naphthalenesulfonate.
4. A method according to claim 1 wherein the second dye component is N-(3-sulfopropyl)aniline.
5. A method of testing a fluid for the presence or concentration of an analyte comprising: applying a fluid sample to a support member having positioned thereon or impregnated therein a composition comprising a composition for a dry chemistry reagent indicator comprising 3-Methyl-6-(M sulfonate)-benzothiazolinone-(2)-hydrazone, wherein M is a positive charge ion providing a stable aqueous salt thereof, a second dye component selected from the group consisting of 3,3- dimethylaminobenzoic acid, 3,5-dichloro-2-hydroxybenzenesulfonic acid,
8-anilino-l-naphthalenesulfonate and N-(3-sulfopropyl)aniline and an oxidase enzyme or a peroxidase enzyme; whereby the support member is adapted for receiving a fluid sample such that the fluid sample contacts said composition and adapted such that the support provides for inspection or reading of the color change produced by said composition after contact with the fluid sample; and reading or measuring the color indication provided by the said composition after contact with said fluid sample.
6. A method according to claim 5 wherein M is a sodium, potassium or ammonium ion.
7. A method according to claim 5 wherein the second dye component is 8-anilino-l-naphthalenesulfonate.
8. A method according to claim 5 wherein the second dye component is N-(3-sulfopropyl)aniline.
PCT/US1997/011177 1997-07-07 1997-07-07 Diagnostic compositions and devices utilizing same WO1998034108A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US08/628,794 US5776719A (en) 1997-07-07 1996-04-05 Diagnostic compositions and devices utilizing same
AU40387/97A AU4038797A (en) 1997-07-07 1997-07-07 Diagnostic compositions and devices utilizing same
DE19781511T DE19781511B4 (en) 1997-07-07 1997-07-07 Device for testing presence or concentration of analyte in fluid sample - comprises support member, and composition positioned on or impregnated in support, containing e.g. 3-methyl-6-(sulphonate)-benzo-thiazolinone-(2)-hydrazone
JP2000572541A JP2002525619A (en) 1997-07-07 1997-07-07 Diagnostic composition and device using the same
PCT/US1997/011177 WO1998034108A1 (en) 1997-07-07 1997-07-07 Diagnostic compositions and devices utilizing same
GB9811951A GB2329246B (en) 1997-07-07 1997-07-07 Diagnostic compositions and devices utilizing same
US09/037,653 US5885790A (en) 1997-07-07 1998-03-10 Diagnostic compositions and devices utilizing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/011177 WO1998034108A1 (en) 1997-07-07 1997-07-07 Diagnostic compositions and devices utilizing same

Publications (1)

Publication Number Publication Date
WO1998034108A1 true WO1998034108A1 (en) 1998-08-06

Family

ID=22261165

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/011177 WO1998034108A1 (en) 1997-07-07 1997-07-07 Diagnostic compositions and devices utilizing same

Country Status (6)

Country Link
US (2) US5776719A (en)
JP (1) JP2002525619A (en)
AU (1) AU4038797A (en)
DE (1) DE19781511B4 (en)
GB (1) GB2329246B (en)
WO (1) WO1998034108A1 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040151A (en) * 1998-03-10 2000-03-21 Mercury Diagnostics, Inc. Diagnostic compositions and devices utilizing same
US5989845A (en) * 1996-04-05 1999-11-23 Mercury Diagnostics, Inc. Diagnostic compositions and devices utilizing same
US20020010406A1 (en) 1996-05-17 2002-01-24 Douglas Joel S. Methods and apparatus for expressing body fluid from an incision
EP1579814A3 (en) 1996-05-17 2006-06-14 Roche Diagnostics Operations, Inc. Methods and apparatus for sampling and analyzing body fluid
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6551842B1 (en) 1999-03-26 2003-04-22 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
US6602719B1 (en) 1999-03-26 2003-08-05 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
US6511814B1 (en) 1999-03-26 2003-01-28 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
US6283982B1 (en) * 1999-10-19 2001-09-04 Facet Technologies, Inc. Lancing device and method of sample collection
US6218571B1 (en) 1999-10-27 2001-04-17 Lifescan, Inc. 8-(anilino)-1-naphthalenesulfonate analogs
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
JP3934107B2 (en) * 2001-06-08 2007-06-20 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Test strip for collecting body fluid and method for collecting body fluid
DE60229988D1 (en) 2001-06-08 2009-01-02 Roche Diagnostics Gmbh Removal device for Körperflussigkeiten
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
EP1404234B1 (en) 2001-06-12 2011-02-09 Pelikan Technologies Inc. Apparatus for improving success rate of blood yield from a fingerstick
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
DE60234598D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7491178B2 (en) * 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7909778B2 (en) * 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7169344B2 (en) * 2002-04-26 2007-01-30 L&L Products, Inc. Method of reinforcing at least a portion of a structure
US20040030349A1 (en) * 2002-08-08 2004-02-12 Mikhail Boukhny Liquefaction handpiece tip
US7731900B2 (en) * 2002-11-26 2010-06-08 Roche Diagnostics Operations, Inc. Body fluid testing device
US7244264B2 (en) * 2002-12-03 2007-07-17 Roche Diagnostics Operations, Inc. Dual blade lancing test strip
ES2522972T3 (en) 2002-12-23 2014-11-19 F.Hoffmann-La Roche Ag Device for testing body fluids
US7582258B2 (en) * 2002-12-23 2009-09-01 Roche Diagnostics Operations, Inc. Body fluid testing device
US20040127818A1 (en) * 2002-12-27 2004-07-01 Roe Steven N. Precision depth control lancing tip
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7214200B2 (en) * 2002-12-30 2007-05-08 Roche Diagnostics Operations, Inc. Integrated analytical test element
US7211052B2 (en) 2002-12-30 2007-05-01 Roche Diagnostics Operations, Inc. Flexible test strip lancet device
EP1581115B1 (en) * 2002-12-30 2009-10-14 Roche Diagnostics GmbH Blood acquisition suspension system
WO2004066822A2 (en) * 2003-01-29 2004-08-12 Roche Diagnostics Gmbh Integrated lancing test strip
EP1628567B1 (en) 2003-05-30 2010-08-04 Pelikan Technologies Inc. Method and apparatus for fluid injection
DK1633235T3 (en) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparatus for sampling body fluid and detecting analyte
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US7220034B2 (en) * 2003-07-11 2007-05-22 Rudolph Technologies, Inc. Fiber optic darkfield ring light
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US7322942B2 (en) * 2004-05-07 2008-01-29 Roche Diagnostics Operations, Inc. Integrated disposable for automatic or manual blood dosing
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US20060002817A1 (en) 2004-06-30 2006-01-05 Sebastian Bohm Flow modulation devices
US8343074B2 (en) 2004-06-30 2013-01-01 Lifescan Scotland Limited Fluid handling devices
US7488298B2 (en) 2004-10-08 2009-02-10 Roche Diagnostics Operations, Inc. Integrated lancing test strip with capillary transfer sheet
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2012028697A1 (en) 2010-09-01 2012-03-08 Eth Zürich, Institute Of Molecular Biology And Biophysics Affinity purification system based on donor strand complementation
CN102305852B (en) * 2011-05-17 2014-12-10 湖州麦迪诺华医疗科技有限公司 Coloring agent for in vitro diagnostic device
CN109030480B (en) * 2018-08-16 2021-03-19 湖南友哲科技有限公司 Sample analysis method, sample analysis device, readable storage medium and computer equipment
FR3130979A1 (en) * 2021-12-16 2023-06-23 Commissariat A L'energie Atomique Et Aux Energies Alternatives COLORIMETRIC DETECTION SYSTEM FOR THE DETECTION OF CHEMICAL COMPOUNDS BY MEANS OF A COLORED INDICATOR FROM THE HYDRAZONES FAMILY

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492754A (en) * 1981-06-23 1985-01-08 Boehringer Mannheim Gmbh Composition and method for the determination of hydrogen peroxide
US4851335A (en) * 1985-09-18 1989-07-25 Boehringer Mannheim Gmbh Process and reagent for the specific determination of HDL cholesterol in serum or plasma
US5082626A (en) * 1988-08-08 1992-01-21 Boehringer Mannheim Gmbh Wedge shaped test strip system useful in analyzing test samples, such as whole blood
US5526120A (en) * 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL268685A (en) * 1960-09-01
US3964871A (en) * 1974-12-18 1976-06-22 Becton, Dickinson And Company Method and device for detecting glucose
DE2460903C3 (en) * 1974-12-21 1981-12-24 Boehringer Mannheim Gmbh, 6800 Mannheim New 3,3 ', 5,5'-Tetraalkylbenzidines
DE2600526C3 (en) * 1976-01-08 1981-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Method for the quantitative determination of substances forming H ↓ 2 ↓ O ↓ 2 ↓ with oxygen under the action of oxidase and the reagent for its implementation
US4059407A (en) * 1976-04-14 1977-11-22 Becton, Dickinson And Company Disposable chemical indicators
DE2625834B2 (en) * 1976-06-09 1978-10-12 Boehringer Mannheim Gmbh, 6800 Mannheim Method for the determination of substrates or enzyme activities
JPS5520471A (en) * 1978-08-01 1980-02-13 Kyowa Hakko Kogyo Co Ltd Hydrogen peroxide quantifying method
US4247631A (en) * 1979-01-31 1981-01-27 Millipore Corporation Reagent and method for the analytic determination of hydrogen peroxide
US4247297A (en) * 1979-02-23 1981-01-27 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4278439A (en) * 1979-12-17 1981-07-14 Miles Laboratories, Inc. Sensitizers for peroxidative activity tests
JPS56117798A (en) * 1980-02-21 1981-09-16 Toyo Jozo Co Ltd Kit for measuring lipoid peroxide
DE3046741A1 (en) * 1980-12-11 1982-07-15 Boehringer Mannheim Gmbh, 6800 Mannheim DETECTION OF NAD (P) H OR SALICYLATE
DE3048799A1 (en) * 1980-12-23 1982-07-08 Boehringer Mannheim Gmbh, 6800 Mannheim REAGENT STRIP FOR ANALYTICAL PURPOSES
US4734360A (en) * 1983-07-12 1988-03-29 Lifescan, Inc. Colorimetric ethanol analysis method and test device
DE3433946A1 (en) * 1984-09-15 1986-03-27 Boehringer Mannheim Gmbh, 6800 Mannheim AGENT AND METHOD FOR DETECTING HYDROGEN PEROXIDE
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5059394A (en) * 1986-08-13 1991-10-22 Lifescan, Inc. Analytical device for the automated determination of analytes in fluids
DE3803757A1 (en) * 1988-02-08 1989-08-17 Boehringer Mannheim Gmbh CHOLESTEROL ESTERASE COLOR SUBSTRATE
JPH0218393A (en) * 1988-07-06 1990-01-22 Nitto Chem Ind Co Ltd Production of artificial quartz crystal
DE3826922A1 (en) * 1988-08-09 1990-02-22 Boehringer Mannheim Gmbh PROCESS FOR THE COLOR-RIMETRIC DETERMINATION OF AN ANALYTE BY ENZYMATIC OXIDATION
WO1990006372A1 (en) * 1988-12-01 1990-06-14 Microprobe Corporation Substrates for peroxidase assaying
US5306623A (en) * 1989-08-28 1994-04-26 Lifescan, Inc. Visual blood glucose concentration test strip
EP0555045B1 (en) * 1992-02-03 1997-10-08 Lifescan, Inc. Improved oxidative coupling dye for spectrophotometric quantitative analysis of analytes
JPH0731498A (en) * 1993-07-20 1995-02-03 Sanwa Kagaku Kenkyusho Co Ltd Determination kit for 1,5-anhydroglucitol and determination method using the kit
DE4343082A1 (en) * 1993-12-17 1995-06-22 Boehringer Mannheim Gmbh Bio-assay based on enzymatic hydrogen peroxide colour reaction
JPH07311498A (en) * 1994-05-18 1995-11-28 Fuji Xerox Co Ltd Image forming method and its control method
US5563031A (en) * 1994-09-08 1996-10-08 Lifescan, Inc. Highly stable oxidative coupling dye for spectrophotometric determination of analytes
AU706456B2 (en) * 1995-03-27 1999-06-17 Lifescan, Inc. Chemical timer for a direct-reading reagent test strip

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492754A (en) * 1981-06-23 1985-01-08 Boehringer Mannheim Gmbh Composition and method for the determination of hydrogen peroxide
US4851335A (en) * 1985-09-18 1989-07-25 Boehringer Mannheim Gmbh Process and reagent for the specific determination of HDL cholesterol in serum or plasma
US5082626A (en) * 1988-08-08 1992-01-21 Boehringer Mannheim Gmbh Wedge shaped test strip system useful in analyzing test samples, such as whole blood
US5526120A (en) * 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring

Also Published As

Publication number Publication date
US5885790A (en) 1999-03-23
GB2329246B (en) 1999-09-29
AU4038797A (en) 1998-08-25
GB2329246A (en) 1999-03-17
US5776719A (en) 1998-07-07
GB9811951D0 (en) 1998-07-29
JP2002525619A (en) 2002-08-13
DE19781511T1 (en) 1999-03-25
DE19781511B4 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
US5776719A (en) Diagnostic compositions and devices utilizing same
US5989845A (en) Diagnostic compositions and devices utilizing same
EP0102504B1 (en) Ascorbate-resistant broad range glucose test composition, test device and method
AU714671B2 (en) Chemical timer for a visual test strip
CA1144456A (en) Indicator composition and test device containing amine oxide and method of use
US5824491A (en) Dry reagent test strip comprising benzidine dye precursor and antipyrine compound
CA1290661C (en) Stable composition for the determination of peroxidatively active substances
US4361648A (en) Color fixed chromogenic analytical element
JP3118029B2 (en) Compositions and methods for assaying ketone bodies
US5516700A (en) Automated urinalysis method
US4649121A (en) Viability test device
EP0029155B1 (en) Stabilized composition and test device for detecting the presence of a sugar in a test sample
JPH08297124A (en) Chemical timer for direct-reading type reagent inspection strip
EP0027236A1 (en) Ascorbate resistant composition, test device and method for detecting a component in a liquid test sample
US4683209A (en) Viability test device
US6040151A (en) Diagnostic compositions and devices utilizing same
IE980414A1 (en) Diagnostic compositions and devices utilizing same
MXPA98004424A (en) Diagnostic compositions and devices utilizing same
FI77941C (en) REAGENTS FOER BESTAEMNING AV GLUKOS, KOLESTEROL, URINSYRA OCH HEMOGLOBIN.
EP0243125A2 (en) Method of measuring phenol and alpha-naphthol, and method of measuring the activity of enzymes
JPS5876100A (en) Use of laccase

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 9811951

Country of ref document: GB

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/004424

Country of ref document: MX

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

EL Fr: translation of claims filed
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
RET De translation (de og part 6b)

Ref document number: 19781511

Country of ref document: DE

Date of ref document: 19990325

WWE Wipo information: entry into national phase

Ref document number: 19781511

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: KR

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8607